Research Article
Patient Safety during ECMO Transportation: Single Center Experience and Literature Review
Table 2
List of included studies. General information, reported transfers, vehicle type, incidents and deaths, distance, and ECMO team persons.
| Author | Year of publication | Center | Reported period | No. of transfers | Transfers (month) | Transfer types | Vehicle (%) | Incidents (%) | Deaths | Distance (km) | Type of support | No. of ECMO team persons | Primary | Secondary | Ground | Air | Min | Max |
| Roch A. et al. [11] | 2013 | Marseille | 48 | 85 | 1.8 | 85 | 0 | 100 | 0 | 0 | 0 | xx | xx | VV | 3 | Bryner B. et al. [12] | 2014 | Michigan | 240 | 221 | 0.9 | 221 | 0 | 69 | 30 | 13 | 1 (R) 5 (N) | xx | xx | VA, VV | 3 | Sherren P.B. et al. [13] | 2015 | London | 12 | 47 | 3.9 | 47 | 0 | 98.4 | 1.6 | 2 | 1 (N) | 3.7 | 550.3 | VV | 3 | Vaja R. et al. [14] | 2015 | Leicestershire | 60 | 102 | 1.7 | 102 | 0 | 77 | 22 | 1 | 0 | 5.8 | 1576.8 | VA, VV | 4 | Raspe C. et al. [15] | 2015 | Halle | 36 | 36 | 1.0 | 36 | 0 | 33 | 64 | 0 | 0 | 3.5 | 115.0 | VV | 3 | Salna M. et al. [16] | 2017 | NY Presbyterian | 105 | 222 | 2.1 | 175 | 47 | 98.2 | 1.8 | 0 | 0 | 3.7 | 11398.2 | VA, VV | 6 | Uribarri A. [17] | 2017 | Salamanca | 33 | 9 | 0.3 | 2 | 7 | 100 | 0 | 0 | 0 | 126.0 | 224.0 | VA, VV | 4 | Yeo H. J. et al. [18] | 2017 | Yangsan | 46 | 18 | 0.4 | 18 | 0 | 100 | 0 | 0 | 0 | 26.0 | 408.0 | VA, VV | 5 | Guenther S.P.W. [19] | 2017 | Munich | 40 | 40 | 1.0 | 40 | 0 | 72.5 | 27.5 | 0 | 0 | 5.6 | 116.4 | VA | 2 | Cianchi G. et al. [20] | 2017 | Florence | 87 | 91 | 1.0 | 91 | 0 | 100 | 0 | 0 | 0 | 5.0 | 407.0 | VV | 4 | Mendes P. V. et al. [21] | 2017 | São Paulo | 48 | 7 | 0.1 | 7 | 0 | 86 | 14 | xx | xx | 0.5 | 163 | VV | 4 | Blecha S. et al. [22] | 2018 | Regensburg | 20 | 52 | 2.6 | 52 | 0 | 67.8 | 32.2 | 11.8 | 0 | 23.0 | 105.0 | VA, VV | 3 | MacDonald M.D. et al. [23] | 2018 | Philadelphia | 36 | 79 | 2.2 | 75 | 4 | 39 | 61 | 1.0 | 1 (N) | 4.8 | 165.7 | VV | 4 | Heuer J.F. [24] | 2018 | Bochum | 60 | 75 | 1.3 | 75 | 0 | 55 | 45 | 0 | 0 | 24.4 | 207.6 | VV | 3 | Brechot N. et al. [25] | 2018 | Paris | 48 | 118 | 2,5 | 118 | 0 | 100 | 0 | 7.6 | 1 (R) | 6 | 25 | VA, VV | 2 | Austin D. E. et al. [26] | 2018 | Sydney | 108 | 164 | 1.5 | 130 | 34 | 58 | 42 | 7.3 | 0 | 16.0 | 1908.0 | VA, VV | 2 | Dalia A.A. et al. [27] | 2019 | Boston | 84 | 51 | 0.6 | 0 | 51 | 100 | 0 | xx | xx | xx | xx | VA | xx | Ehrentraut S.F. et al. [28] | 2019 | Bonn | 120 | 126 | 1.1 | 126 | 0 | 85 | 15 | 6.3 | 4 (N) | 7.0 | 548.0 | VA, VV | 2 | Bonadonna D. et al. [29] | 2019 | Durham | 24 | 132 | 5.5 | 132 | 0 | 100 | 0 | 0 | 0 | xx | xx | VA, VV | 4 | Wilhelm M.J. et al. [30] | 2019 | Zurich | 88 | 58 | 0.7 | 49 | 9 | 40 | 60 | 0 | 0 | 3.0 | 225.0 | VA, VV | 3 | Fletcher-Sandersjoo A. et al. [31] | 2019 | Karolinska | 78 | 908 | 11.0 | 800 | 108 | 40.3 | 59.3 | 20.0 | 2 (R) | 6.9 | 13447.0 | VA, VV | 2 | Puslecki M. et al. [32] | 2019 | Poznan | 36 | 6 | 0.2 | 6 | 0 | 100 | 0 | xx | 0 | 3.0 | 200.0 | VA, VV | 4 |
|
|
VV: venovenous; VA: venoarterial; R: related; N: not related.
|